AI-Assisted surgery aims to improve brain bleed recovery

NCT ID NCT07077343

Recruiting now Disease control Sponsor: Xiaolei Chen Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares two approaches for treating moderate brain hemorrhages: AI-assisted minimally invasive surgery to remove the clot versus standard medical care. About 680 patients will be randomly assigned to one of the two groups. The goal is to see which method leads to better functional recovery and fewer complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: AI-assisted navigated hematoma aspiration (minimally invasive surgery)
What this could lead to: If it works, this could provide a safer, more effective way to treat brain bleeds, potentially improving recovery and reducing disability.
What could go wrong: This is a mid-stage trial, and the surgery may not prove better than standard care. Risks include infection, bleeding, or complications from the procedure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTRACEREBRAL HEMORRHAGE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

intracerebral hemorrhage

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INTRACEREBRAL HEMORRHAGE

Contacts and locations

Locations

Chinese PLA General Hospital
RECRUITING

Beijing, Beijing Municipality, 100853, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.